by Cristina Sáez
A new study reveals that a molecule produced by gut bacteria can trigger atherosclerosis, shedding light on why some healthy individuals develop cardiovascular disease.
by Andreu Prados
Cardiovascular diseases remain one of the most pressing public health concerns, demanding innovative research to identify novel causes. A recent Nature study reported that imidazole propionate made by gut bacteria contributes to atherosclerosis development, supporting its potential role as a biomarker of subclinical disease.
by Cristina Sáez
The fundamental role of gut bacteria in overall health has been recognized for years. Imbalances in its composition have been linked to autoimmune, gastrointestinal, and metabolic diseases, and now also to cardiovascular conditions. Increasingly, scientists are studying the gut-heart axis and suggest that the gut microbiota could become a new therapeutic target for preventing and treating heart diseases.
Gut microbiota alterations in obesity remain the subject of debate. Writing in Nature, Vieira-Silva and colleagues found that the undesirable Bacteroides 2 enterotype was more frequent in people with a higher body mass index, but not if they were taking statins.
by GMFH Editing Team
The ‘paleo’ diet is usually promoted as a means of improving gut health. But despite its popularity, new observational data reveal that individuals consuming this diet show a shift in their gut microbiota composition, along with increased serum trimethylamine-N-oxide (TMAO) levels.
by Andreu Prados
A new study has found that arterial stiffness is inversely correlated with gut microbiome diversity and the abundance of specific gut microorganisms in women.
